Mechanical circulatory support for heart failure: Past, present and a look at the future

被引:0
作者
机构
[1] Department of Thoracic and Cardiovascular Surgery, Miller Family Heart and Vascular Institute, Cleveland Clinic, Cleveland
[2] Kaufman Center for Heart Failure, Miller Family Heart and Vascular Institute, Cleveland Clinic, Cleveland
[3] Department of Biomedical Engineering, Lerner Research Institute, Cleveland Clinic, Cleveland
关键词
circulation; heart; heart failure; heart transplantation; heart-assist devices; pumps;
D O I
10.1586/erd.12.69
中图分类号
学科分类号
摘要
Heart transplantation remains the gold standard for long-term cardiac replacement, but a shortage of donor organs will always limit this option. For both transplant-eligible and noneligible patients, advances in mechanical circulatory support have revolutionized the options for the management of end-stage heart failure, and this technology continues to bring us closer to a true alternative to heart transplantation. This review provides a perspective on the past, present and future of mechanical circulatory support and addresses the changes in technology, patient selection and management strategies needed to have this therapy fully embraced by the heart failure community, and perhaps replace heart transplantation either as the therapy of choice or as a strategy by which to delay transplantation in younger patients. © 2013 Expert Reviews Ltd.
引用
收藏
页码:55 / 71
页数:16
相关论文
共 83 条
[71]  
Timms D., Fraser J., Hayne M., Dunning J., McNeil K., Pearcy M., The BiVACOR rotary biventricular assist device: Concept and in vitro investigation, Artif. Organs, 32, 10, pp. 816-819, (2008)
[72]  
Kormos R.L., Teuteberg J.J., Pagani F.D., Et al., Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: Incidence, risk factors, and effect on outcomes, J. Thorac. Cardiovasc. Surg., 139, 5, pp. 1316-1324, (2010)
[73]  
Drakos S.G., Janicki L., Horne B.D., Et al., Risk factors predictive of right ventricular failure after left ventricular assist device implantation, Am. J. Cardiol., 105, 7, pp. 1030-1035, (2010)
[74]  
Bhama J.K., Kormos R.L., Toyoda Y., Teuteberg J.J., McCurry K.R., Siegenthaler M.P., Clinical experience using the Levitronix CentriMag system for temporary right ventricular mechanical circulatory support, J. Heart Lung Transplant., 28, 9, pp. 971-976, (2009)
[75]  
Fukamachi K., Shiose A., Massiello A.L., Et al., Implantable continuous-flow right ventricular assist device: Lessons learned in the development of a cleveland clinic device, Ann. Thorac. Surg., 93, 5, pp. 1746-1752, (2012)
[76]  
Saito S., Sakaguchi T., Miyagawa S., Et al., Biventricular support using implantable continuous-flow ventricular assist devices, J. Heart Lung Transplant., 30, 4, pp. 475-478, (2011)
[77]  
Takagaki M., Wurzer C., Wade R., Et al., Successful conversion of TandemHeart left ventricular assist device to right ventricular assist device after implantation of a HeartMate XVE, Ann. Thorac. Surg., 86, 5, pp. 1677-1679, (2008)
[78]  
Potapov E., Schweiger M., Vierecke J., Et al., Discontinuation of HeartWare RVAD support without device removal in chronic BIVAD patients, ASAIO J., 58, 1, pp. 15-18, (2012)
[79]  
Mehta S.M., Pae Jr. W.E., Rosenberg G., Snyder A.J., Weiss W.J., Lewis J.P., Frank D.J., Thompson J.J., Pierce W.S., The LionHeart LVD-2000: A completely implanted left ventricular assist device for chronic circulatory support, Annals of Thoracic Surgery, 71, 3 SUPPL., (2001)
[80]  
Dowling R.D., Gray Jr. L.A., Etoch S.W., Laks H., Marelli D., Samuels L., Entwistle J., Couper G., Vlahakes G.J., Frazier O.H., The AbioCor implantable replacement heart, Annals of Thoracic Surgery, 75, 6 SUPPL., (2003)